an insight into how novel agents are influencing survival outcomes in patients with mf
Published 2 years ago • 104 plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
1:04
exciting updates in mf: novel targets and agents
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
4:48
an insight into the management of cytopenias in mf
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
9:25
mgus diagnosis: a step-by-step approach
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
3:22
advances and unanswered questions in aml: novel agents, mrd assessment, and immunotherapy
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:09
heart transplantation in attr amyloidosis
-
1:15
bringing novel agents to the frontline setting in myeloma
-
2:19
how cutting-edge research is changing outcomes in myeloma and the need for novel endpoints in trials
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
1:30
insights into the manifest-2 study
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies